Issue 18/2015 - Meltblown nonwoven fiber was successfully developed
Time of Update: 2022-11-13
, Ltd. that the nano-doped preparation of durable electret composite meltblown nonwoven materials and preparation technology jointly developed by the company, Tianjin Polytechnic University and the Munitions Equipment Research Institute of the General Logistics Department of the Chinese People's Liberation Army exceeded the international standard of the American 3M company.
The researchers captured how genes fold and work with unprecedented resolution
Time of Update: 2022-10-20
Source: Vicky Neguembor/CRG and Pablo Dans/IRB BarcelonaA new imaging technique captures the structure of the human genome at unprecedented resolution, revealing how individual genes fold at the nucleosome level, the building blocks that make up the three-dimensional structure of the genome.
Open up a new direction for the treatment of hepatitis B virus
Time of Update: 2022-10-20
In 2016, a UNIGE team led by Michel Strubin, an associate professor at the Geneva Center for Inflammation Research in the Department of Microbiology and Molecular Medicine at the University of Michigan School of Medicine, revealed a mechanism critical to understanding the disease: When our immune system defends itself, a complex of six proteins called SMC5/6 present in our cells — the interdependent group — detects viral DNA 。 The virus then fights back, producing a special protein, protein X.
Shandong Seawater Comprehensive Utilization Research Center was inaugurated
Time of Update: 2022-09-30
Ruan Guoling, director of the Tianjin Institute of Seawater Desalination and Comprehensive Utilization of the Ministry of Natural Resources, said that the Institute of Desalination will play a role as a bridge and platform to bring advanced technologies in the field of desalination to Shandong, and promote the experience gained in the field of desalination in Shandong throughout the country.
The performance exceeds PPC, Shaanxi Coal develops new carbon dioxide-based degradable material track
Time of Update: 2022-09-18
, Ltd. released the second public participation in the public participation in the environmental impact assessment of the carbon dioxide-based degradable material-polycyclohexylcarbonate (PCHC) preparation pilot project The Degradable and Recyclable Center was informed that recently, Shaanxi Coal Industry Chemical Technology Research Institute Co.
British Journal of Cancer: Eat while it's hot, it will cause cancer
Time of Update: 2022-08-19
Recently, the team of Li Zhiyuan from Guangzhou Institute of Biomedicine and Health, Chinese Academy of Sciences published a research paper entitled: Thermal stress involved in TRPV2 promotes tumorigenesis through the pathways of HSP70/27 and PI3K/Akt/mTOR in esophageal squamous cell carcinoma in the British Journal of Cancer.
Xiamen University's Nature sub-journal publishes a new method for editing near-infrared second-region fluorescent probes based on genetic engineering strategies
Time of Update: 2022-08-12
Cl-dye undergoes nucleophilic substitution reaction with HSA variant Cys476 and forms a fluorescence-enhanced probeResearcher Tian Rui of our school is the first author and corresponding author of the paper , Yanbao Yu (now at the University of Delaware) from the J Craig Venter Institute in the United States , Professor Zhu Shoujun from Jilin University, and Professor Chen Xiaoyuan from the National University of Singapore are the joint correspondents of the paper author .
The scientific and technological research project successfully passed the quality inspection of construction projects assisted by Henan Metrology Institute
Time of Update: 2022-05-21
” "The results of this project have achieved integrated innovation in the research on the traceability method of construction engineering quality testing instruments and equipment and the automatic development of related measurement standard devices.
The New "Revolution" of Cell Therapy——Global R&D Overview of TCR-T Therapy
Time of Update: 2022-04-28
TCR-T technology has undergone four iterations in the development process: 01 The first generation of TCR-T is a subset of T cells that are specifically recognized by tumor antigens isolated from patient T cells, expanded in vitro and then reinfused for treatment .
34 people were actively infected with the new crown, and the Nature sub-journal released the results of the world's first human challenge test
Time of Update: 2022-04-27
On March 31, 2022, a paper titled "Safety, tolerability and viral kinetics during SARS-CoV-2 human challenge" was published in Nature Medicine, announcing the results of the world's first new crown human challenge test .
What are the new drugs approved by the FDA in 2021
Time of Update: 2022-02-21
Summary of CDER Approved Drugs in 2021 Additional additions to further approvals by the FDA's Center for Biologics Evaluation and Research (CBER) include landmark mRNA vaccines and CAR-T cell products (Table 2) .
Italy: 527 people have been infected before the discovery of No. 1 new crown case in the country
Time of Update: 2021-12-02
7. 5 The study pointed out that this is not the first time that Italian researchers have confirmed that the new coronavirus has spread in the country earlier than February 2020 .
The team of Professor Hu Yongfei from China Agricultural University has constructed the largest chicken gut microbial reference genome and gene set in the world
Time of Update: 2021-12-01
Editor in charge: Food Science 0 Recently, the team of Professor Hu Yongfei from the College of Animal Science and Technology of China Agricultural University published the title "metagenome-assembled genomes and gene catalog from the chicken gut microbiome aid research papers in deciphering antibiotic resistomes "of .
Stanford University $12 million for stem cell trials
Time of Update: 2021-11-13
This treatment, named T-allo10, aims to improve the immune response to pathogens and cancer without increasing the possibility of graft-versus-host disease in patients who must receive transplants from an incompletely matched donor .
Inventory of the domestic Class 1 NDA applications undertaken by CDE for the first time from January to May 2021
Time of Update: 2021-06-23
A multi-center, open, single-arm Phase II clinical study evaluating the efficacy of the drug in locally advanced or metastatic NSCLC patients who have developed resistance after first-generation or second-generation EGFR-TKI treatment and are positive for EGFR-T790M mutations And safety .